Drug names Flashcards
Antibiotic topics
Substances Mechanism Mode of Action Pharmacokinetics Spectrum Indications Side effects Resistance
- Drugs of autonomous NS - Parasympathetic Substances
Parasympathomimetics
Parasympatholytics
- Parasympathomimetics
Direct: achetylcholine carbachol bethanecol methacholine pilocarpine
Indirect: physostigmine pyridostigmine neostigmine edrophonium organophosphates
- Parasympatholytics
atropine glycopyrrolate homatropine ipratropium benzethemide butyl-scopolamine tropicamide levadopa
- Drugs of autonomous NS - Sympathetic
Sympathomimetics:
- Non-specific
- Specific:
- -B1 agonists
- -B2 agonists
- -A1 agonists
- -A2 agonists
Sympatholytics:
- A antagonists
- -Non-specific
- -A1 antagonists
- -A2 antagonists
- B antagonist
- -Non-specific
- -Specific (mostly B1)
- Sympathomimetics - Non-specific
adrenaline
noradrenaline
dopamine
- Sympathomimetics - Specific - B1 agonists
dobutamine
isoproterenol
- Sympathomimetics - Specific - B2 agonists
clenbuterol salmeterol terbutaline isoxsupine salbutamol
- Sympathomimetics - Specific - A1 agonists
phenylephrine xylametazoline oxymetazoline naphtazoline tetrizoline phenylpropanolamine ephedrine amphetamine
- Sympathomimetics - Specific - A2 agonists
xylazine
detomidine
medetomidine
romifidine
- Sympatholytics - A antagonists
Non-specific:
phenoxybenzamine
phentolamine
tolazoline
Specific:
- A1 antagonists:
- -prazosine
- -doxazosine
- A2 antagonists:
- -atipamezole
- -yohimbine
- Sympatholytics - B antagonists
Non-specific:
propranolol
timolole
Specific: (B1)
metaprolole
atenolole
- Sympathetic NS - receptors
A1
A2
B1
B2
A1
SM contraction, vasoconstriction (Increase PR), mydriasis
A2
Inhibition of neurotransmitter release (NA)
GI relaxation
Inhibition of insulin release
B1
Cardiac effects: negative inotropic, chronotropic
B2
Vasodilation, bronchodilation, uterus relaxation
- Tranquilizer sedatives (neuroleptics)
Phenothiazines
Butyrophenones
- Phenothiazines
chloropromazine propionyl-promazine acepromazine thiethylperazine trifluorperazine fluphenazine perphenazine promethazine
- Butyrophenones
azaperone
droperidol
haloperidol
fluanison
- Hypnosedatives
A2 agonists + antagonists
benzodiazepines + antagonists
barbiturates
- A2 agonists + antagonists
xylazine detomidine medetomidine dexmedetomidine romifidine
Antagonists:
atipamezole
yohimbine
- Barbiturates
Long acting:
phenobarbital
Short acting:
pentobarbital
Ultra short acting: thiopental thiamilal hexobarbital venobarbital methohexital
- CNS stimulants: Anticonvulsives
CNS stimulants
Anticonvulsives
Status Epilepticus
- Anticonvulsives
Barbiturates
Benzodiazepines
Others
- Anticonvulsives - Barbiturates
phenobarbital
pentobarbital
primidone
- Anticonvulsives - Benzodiazepines
diazepam
clonazepam
carbamazepine
- Anticonvulsives - Others
phenytoin valproic acid gabopentin felbamate topiramate lamotrigine bromide salts vigabatrin propofol
- Status Epilepticus
diazepam
pentobarbital
propofol
isoflurane/sevoflurane
- Opioids
morphine butorphanol buprenorphine fentanyl tramadol codeine methadone etorphine pethidine meperidine pentazosine
- Opioid antagonists
Neuroleptanalgesia combos
Opioid antagonists:
naloxone
naltrexone
diprenorphine
Combos: etorphine + acepromazine butorphanol + acepromazine fentanyl + fluanisone fentanyl + droperidol
- Injectable anaesthetics
Barbiturates Propofol Propandiol Imidazoles Dissociative anaesthetics Steroid anaesthetics
- Injectable anaesthetics - Barbiturates
pentobarbital
thiopental
thiamilal
methohexital
- Injectable anaesthetics - Imidazoles
etomidate
metomidate
- Injectable anaesthetics - Dissociative anaesthetics
ketamine
tiletamine
- Injectable anaesthetics - Steroid anaesthetics
alfaxalon + alfadolon
alfaxalon
- Inhalational anaesthetics
nitrous oxide N2O
Halogenated volatile liquids: halothane enflurane isoflurane desflurane sevoflurane
- Inhalational anaesthetics - MAC potency
halothane>isoflurane>sevoflurane>desflurane>N2O
- Local anaesthetics
Esters: procaine chloroprocaine tetracaine benzocaine cocaine
Amides: lidocaine (lignocaine) prilocaine mepivacaine bupivacaine ropivacaine
- Local anaesthetics - Toxicity
mepivacaine
- Local anaesthetics - Neuron function loss
pain>touch>deep pressure>motor function
- Local anaesthetics - Clearance
prilocaine>lidocaine>mepi/ropivacaine>bupivacaine
- Myorelaxants
Central
Peripheral
SM relaxants
- Myorelaxants - Central
guaifenesin
baclophen
carisoprodol
methocarbamol
- Myorelaxants - Peripheral
Non-depolarizing (competitive): d-tubocurarin atracurium aminosteroids pancuronium vecuronium rocuronium gallamine cisatracuronium mivacuronium benzylisoquinolines
Depolarizing:
suxamethorium (succinyl choline)
- Myorelaxants - SM relaxants (spasmolytics)
Direct acting
Parasympatholytics
Sympathomimetics
Other (NSAIDS, Phenothiazines)
- Myorelaxants - SM relaxants (spasmolytics) - Direct acting - Parasympatholytics
Direct acting:
papaverine
drotaverine
Parasympatholytics: atropine hyoscyamine scopolamine ipratropium tropicamide
- Pharmacology of inflammation
Acute phase
Chronic phase
Know
- Pharmacology of inflammation - Acute phase
Antacoids: histamine (cytokine) serotonin (cytokine) bradykinin, kallidin (kinins) prostaglandins (eicosanoid) leukotrienes (eicosanoid) angiotensin, neurotensin NO complement proteins endothelins cytokines -interleukins -GM-CSF -G-CSF -TNF alpha -interferons
- Pharmacology of inflammation - Chronic phase
cytokines
- interleukins
- GM-CSF
- G-CSF
- TNF alpha
- Pharmacology of inflammation - Know
STAT - inhibits JAK-mediated pathway
Drug name = Oclatinib (IL- inhibitor)
- NSAIDs
Salicylates (1g) Acetic acid derivatives (1g) Proprionic acid derivatives Anthranidic acids (1g) Oxicams Aniline derivatives Pyrazole derivatives (1g) Coxibs (3g) COX 2 selective inhibitors
- NSAIDs - Salicylates (1g)
sulfosalazine
acetyl-salicylic acid (aspirin)
- NSAIDs -Acetic acid derivatives (1g)
diclofenac
etodolac
- NSAIDs - Proprionic acid derivatives
1g:
ketoprofen
vedaprofen
2g:
carprofen
ibuprofen
naproxen
- NSAIDs - Anthranidic acids (1g)
tolfenamic acid
flunixin-meglumide
- NSAIDs - Oxicams
1g: piroxicam
2g: meloxicam
- NSAIDs - Aniline derivatives
1g: paracetamol
2g: nimesulide
- NSAIDs - Pyrazole derivatives (1g)
metamizole
phenylbutazone
- NSAIDs - Coxibs (3g)
deracoxib
firocoxib
mavacoxib
robenacoxib
- NSAIDs - COX 2 selective inhibitors
celecoxib rofecoxib valdecoxib meloxicam peroxicam
20.
Cytokine inhibitors
Thromboxane antagonists
Thromboxane synthesis inhibitors
Leukotriene inhibitors
- Cytokine inhibitors
TNF alpha inhibitors:
etanercept
infliximab
adalimumab
IL-1 inhibitors:
anakinra
- Thromboxane antagonists
TXA2 receptor antagonists:
ridogrel
- Thromboxane synthesis inhibitors
dazoxiben
pirmagrel
- Leukotriene inhibitors
LT-synthesis inhibitors (inhibit LOX):
zileuton
fenleuton
adenosine
LT receptor antagonists:
montelukast
zafirlukast
JAK inhibitors:
ocalcitinib
- Antihistamines
1st generation (cross BBB): Ethanolamines Phenothiazines Piperazines Ethylenediamines cyproheptadin dimetinden
2nd generation (do not cross BBB)
Loratadine (claritin)
Cetrizine
- Antihistamines - 1st generation (cross BBB) - Ethanolamines
diphenhydramine
dimenhydrinate
clemastine
- Antihistamines - 1st generation (cross BBB) - Phenothiazines
promethazine
acepromazine
- Antihistamines - 1st generation (cross BBB) - Piperazines
hydroxyzine
cyclizine
chlorcyclizine
- Antihistamines - 1st generation (cross BBB) - Ethylenediamines
chlorpyramine
tripelenamine
- Pharmacology of Immunosuppression
Glucocorticoids
Cytotoxic agents
Lymphocyte signalling inhibitors
Cytokine inhibitors
- Pharmacology of Immunosuppression - Glucocorticoids
e.g prednisolone
- Pharmacology of Immunosuppression - Cytotoxic agents
Antimetabolites azathioprine-->b-mercaptopurine methotrexate mycophenolate mofetil-->mycophenolic acid luflunomide
Alkylating agents
cyclophosphamide
- Pharmacology of Immunosuppression - Lymphocyte signalling inhibitors
cyclosporine
tacrolimus
sirolimus
pimecrolimus
- Pharmacology of Immunosuppression - Cytokine inhibitors
TNF alpha inhibitors:
etanercept
infliximab
aldalimumab
IL-1 inhibitor:
anakinra
- Glucocorticoids + relative potency
Short acting (8-12h) Medium Duration of Action (24-48h) Long acting (48-72h) Local (inhalational) Ester, salts
- Glucocorticoids + relative potency - Short acting (8-12h)
cortisole 1
cortisone 1
- Glucocorticoids + relative potency - Medium Duration of Action (24-48h)
prednisone 4
prednisolone 4
methylprednisolone 5-7
triamcinolone 5-10
- Glucocorticoids + relative potency - Long acting (48-72h)
dexamethasone 25-30
betamethasone 25-30
flumethasone 100
- Glucocorticoids + relative potency - Local (inhalational)
baclomethasone 300-400
fluticasone 400-500
- Glucocorticoids + relative potency - Ester, salts
Na phosphate, Na succinate (water soluble-given IV, short acting)
–>
Diproprionate, phenylproprionate, acetate (not water soluble, not IV –> only IM, longer duration of action)
–>
Acetonide/Valerate (least water soluble, longest absorption and duration (1 month)
- Anti-arrythmics
Class 1 : Na-Blockers Class 2 : B-Blockers Class 3 : K-Blockers Class 4 : Ca-Blockers Class 5 : Other
- Anti-arrythmics - Class 1 : Na-Blockers
1A:
quinidine
procainamide
1B: lidocaine mexiletine tocainide phenytoin
1C:
flecainide
- Anti-arrythmics - Class 2 : B-Blockers
1st generation : B1 & B2
propanolol
2nd generation : B1
methoprolol
atenolol
esmolol
3rd generation:
cervediol
- Anti-arrythmics - Class 3 : K-Blockers
sotalol amiodarone (1-4 class effects)
- Anti-arrythmics - Class 4 : Ca-Blockers
Dihydropyridine types: amlodipine nifedipine Non-dihydropyridine types: verapamil diltiazem
- Anti-arrythmics - Class 5 : Other
digoxin
atropine
- Positive inotropes, cardiogenic drugs
Acute Heart Failure:
epinephrine
dobutamine
dopamine
Chronic Heart Failure:
- cardiotoxic:
- -(digitalis glycosides) (digoxin + digitoxin)
- PDE inhibitors:
- -pimobendan
- Cardiovascular volume regulation
ACE inhibitors Angiotensin 2 receptor antagonists Organic nitrates Ca-Blockers Non-Ca-Blockers Other
- Cardiovascular volume regulation - ACE inhibitors
captopril enalapril-->enalaprilat ramipril-->ramiprilat benazepril-->benazeprilat lisinopril
- Cardiovascular volume regulation - Angiotensin 2 receptor antagonists
losartan
telmisartan
valsartan
- Cardiovascular volume regulation - Organic nitrates
nitroglycerin
nitroprusside-Na
- Cardiovascular volume regulation - Ca-Blockers
amlodipine
nifedipine
- Cardiovascular volume regulation - Non-Ca-Blockers
verapamil
diltiazem
- Cardiovascular volume regulation - Other
A1 antagonists:
prazosin
doxazosin
hydrazolin
PDE inhibitors:
pimobendan
- Diuretics
- Cardiac diuretics
- Osmotic diuretics
- Natriuretics
- a. CA inhibitors (proximal convoluted tubule)
- b. Loop diuretics (loop of Henle)
- c. Thiazides (distal convoluted tubule)
- d. Potassium sparing diuretics (collecting duct)
- Diuretics - 1. Cardiac diuretics
digoxin
Xanthine diuretics:
caffeine
theophylline
theobromine
ACE inhibitors: enalapril benazepril ramipril captopril lisinopril
- Diuretics - 2. Osmotic diuretics
mannitol
glycerine
- Diuretics - Natriuretics - CA inhibitors (proximal convoluted tubule)
dorsolamide
brinzolamide
acetazolamide
- Diuretics - Natriuretics - Loop diuretics (loop of Henle)
furosemide
torsemide
etacrinic acid
- Diuretics - Natriuretics - Thiazides (distal convoluted tubule)
chlorothiazole
hydrochlorthiazole
clopamide
- Diuretics - Natriuretics - Potassium sparing diuretics (collecting duct)
Electrogenic Na channel inhibitors:
amiloride
triametenine
Aldosterone antagonists:
spironolactone
- Pharmacology of Vascular tone
Organic nitrates Ca channel blockers K channel openers Endothelin receptor antagonists Other
- Pharmacology of Vascular tone - Organic nitrates
nitroglycerin
nitroprusside-Na
- Pharmacology of Vascular tone -Ca channel blockers
Dihydropyridines:
amlodipine
nifedipine
Non-dihydropyridines:
verapamil
diltiazem
- Pharmacology of Vascular tone - Endothelin receptor antagonists
bosentan
- Pharmacology of Vascular tone - Other
A1 receptor antagonists:
parazosin
doxazosin
hydralazin
PDE inhibitors:
pimobendan
ACE inhibitors: captopril enalapril benazepril ramipril lisinopril
- Pharmacology of haemostasis & thrombosis -
Antiplatelet agents Anticoagulants -Vit K antagonists -Other Thrombolytic agents
Inhibitors of anticoagulants
- Pharmacology of haemostasis & thrombosis - Antiplatelet agents
COX inhibitors
acetyl-salicylic acid (aspirin)
ADP recepetor inhibitors
ticlopidin
clopidogrel
- Pharmacology of haemostasis & thrombosis - Anticoagulants -Vit K antagonists
Warfarin Heparin -Non-fractionated: --Na-heparin --Ca-heparin -Low Molecular Weight Heparin: --dalteparin --fraxiparin --enoxaparin
- Pharmacology of haemostasis & thrombosis - Anticoagulants - Other
Xa factor inhibitor: fondaparinux Direct thrombin inhibitors: hirudine lepirudine desirudine
- Pharmacology of haemostasis & thrombosis - Thrombolytic agents
streptokinase tPA analogues: alteplas tenecteplas reteplas
- Pharmacology of haemostasis & thrombosis - Inhibitors of anticoagulants
protamine
ethamsylate
- Pharmacology of Haematopoiesis & Immunomodulation
Haematopoiesis: anaemia due to EPO deficiency iron deficiency anaemia anaemia due to infection vit B12
Immunomodulation: levamisole (inhibited by atropine) n-n-dimethylglycine interferons granulocyte colony stimulating factors
- Pharmacology of Haematopoiesis
Anaemia due to EPO deficiency
Iron deficiency anaemia
Anaemia due to infection
Vit B12
- Pharmacology of Immunomodulation
levamisole (inhibited by atropine) n-n-dimethylglycine Interferons interferon-omega virbagen-omega Granulocyte colony stimulating factors filgrastin sargramostim
- Pharmacology of Haematopoiesis - Anaemia due to EPO deficiency
EPO as a drug:
epoetin-a (rhEPO-a)
darbepoietin
- Pharmacology of Haematopoiesis - Iron deficiency anaemia
Iron supplement: PO (Fe2+) -iron fumarate -iron gluconate IM (Fe3+) -iron dextran (inhibited by deferoxamin)